• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估严重斑秃患者生活质量的一种方法:一项意大利多中心研究。

Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study.

机构信息

UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy.

Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.

出版信息

Front Public Health. 2024 Aug 16;12:1415334. doi: 10.3389/fpubh.2024.1415334. eCollection 2024.

DOI:
10.3389/fpubh.2024.1415334
PMID:39220459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11363427/
Abstract

OBJECTIVE

The prevalence of anxiety and depression in patients diagnosed with Alopecia Areata (AA) is very high and this significant burden of psychological symptoms threatens the Health-Related Quality of Life (HRQoL) of affected patients. Indeed, AA often does not produce significant physical symptoms, but it nonetheless disrupts many areas of mental health. Clinical assessment of disease severity may not reliably predict patient's HRQoL, nor may it predict the patient's perception of illness. For this reason, considerable effort has been made to apply and develop measures that consider patient's perception and assess the HRQoL of individuals affected by AA. The aim of this multicentric study was to provide the Italian version of the Skindex-16AA and to evaluate its psychometric properties in a clinical sample of consecutive patients with moderate-to-severe AA.

METHODS

This is a longitudinal, multicenter, observational study. Patients returned for follow-up visits at 4-, 12-, and 24-weeks. The analyses of the current work aimed to confirm the factorial structure of the Skindex-16AA. In the case of non-fit, an alternative structure for the model was proposed, using an Exploratory Graph Analysis and the Bayesian approach.

RESULTS

The sample was composed of 106 patients with AA. Alopecia Universalis was the most frequently diagnosed type of alopecia at all time points. The analyses on the Skindex-16AA revealed that a two-factor structure with eight items fit the data best (Bayesian Posterior Predictive Checking using 95% Confidence Interval for the Difference Between the Observed and the Replicated Chi-Square values = -6.246/56.395, Posterior Predictive -value = 0.06), and reported satisfactory psychometric properties (i.e., internal consistency and convergent validity).

CONCLUSION

The Skindex-8AA demonstrated optimal psychometric properties (i.e., convergent and construct validity, and test-retest reliability) measured in a sample of patients with AA, that may suggest that it is an appropriate tool to measure the HRQoL in AA patients. However, further studies are needed in order to confirm and tested other psychometric features of this tool.

摘要

目的

患有斑秃(AA)的患者普遍存在较高的焦虑和抑郁发生率,这些严重的心理症状负担威胁着受影响患者的健康相关生活质量(HRQoL)。实际上,AA 通常不会产生明显的身体症状,但它仍然会扰乱心理健康的许多方面。疾病严重程度的临床评估可能无法可靠地预测患者的 HRQoL,也无法预测患者对疾病的感知。出于这个原因,人们已经付出了相当大的努力来应用和开发考虑患者感知并评估 AA 个体 HRQoL 的措施。本多中心研究的目的是提供 Skindex-16AA 的意大利语版本,并在中度至重度 AA 连续患者的临床样本中评估其心理测量特性。

方法

这是一项纵向、多中心、观察性研究。患者在 4、12 和 24 周时返回进行随访。当前工作的分析旨在确认 Skindex-16AA 的因子结构。在不适合的情况下,使用探索性图形分析和贝叶斯方法提出了模型的替代结构。

结果

该样本由 106 名 AA 患者组成。在所有时间点,全身性脱发是最常诊断的脱发类型。对 Skindex-16AA 的分析表明,具有八项条目的两因素结构最适合数据(使用 95%置信区间的贝叶斯后验预测检查观察到的和复制的卡方值之间的差异 = -6.246/56.395,后验预测值 = 0.06),并报告了令人满意的心理测量特性(即,内部一致性和收敛效度)。

结论

在 AA 患者样本中,Skindex-8AA 表现出最佳的心理测量特性(即收敛和构念效度以及测试-重测信度),这表明它是衡量 AA 患者 HRQoL 的合适工具。然而,需要进一步的研究来确认和测试该工具的其他心理测量特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd8/11363427/5aa673c9baab/fpubh-12-1415334-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd8/11363427/5aa673c9baab/fpubh-12-1415334-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd8/11363427/5aa673c9baab/fpubh-12-1415334-g0001.jpg

相似文献

1
Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study.评估严重斑秃患者生活质量的一种方法:一项意大利多中心研究。
Front Public Health. 2024 Aug 16;12:1415334. doi: 10.3389/fpubh.2024.1415334. eCollection 2024.
2
Alopecia areata and health-related quality of life: a systematic review and meta-analysis.斑秃与健康相关生活质量:系统评价和荟萃分析。
Br J Dermatol. 2016 Sep;175(3):561-71. doi: 10.1111/bjd.14497. Epub 2016 Jul 2.
3
Reliability and validity of a measure to assess the health-related quality of life of women with alopecia areata.评估斑秃女性健康相关生活质量的测量工具的信度和效度。
Clin Exp Dermatol. 2023 Jun 5;48(6):681-684. doi: 10.1093/ced/llad066.
4
Development of the alopecia areata symptom impact scale.斑秃症状影响量表的编制
J Investig Dermatol Symp Proc. 2013 Dec;16(1):S51-2. doi: 10.1038/jidsymp.2013.19.
5
Health-Related Quality of Life (HRQoL) in alopecia areata patients-a secondary analysis of the National Alopecia Areata Registry Data.斑秃患者的健康相关生活质量(HRQoL)——国家斑秃注册数据的二次分析
J Investig Dermatol Symp Proc. 2013 Dec;16(1):S49-50. doi: 10.1038/jidsymp.2013.18.
6
HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety.脱发患者的生活质量与斑秃、雄激素性脱发和休止期脱发:人格特质和心理社会焦虑的作用。
J Eur Acad Dermatol Venereol. 2019 Mar;33(3):608-611. doi: 10.1111/jdv.15327. Epub 2018 Dec 2.
7
Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries.医生和患者报告的斑秃严重程度及对生活质量的影响:来自五个欧洲国家的真实世界调查结果
Dermatol Ther (Heidelb). 2023 Dec;13(12):3121-3135. doi: 10.1007/s13555-023-01057-0. Epub 2023 Oct 27.
8
Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review.斑秃患者的健康相关生活质量(HRQoL):系统评价。
J Am Acad Dermatol. 2016 Oct;75(4):806-812.e3. doi: 10.1016/j.jaad.2016.04.035. Epub 2016 Jul 16.
9
Predictors of QOL in Patients with Alopecia Areata.斑秃患者生活质量的预测因素。
J Invest Dermatol. 2022 Oct;142(10):2646-2650.e3. doi: 10.1016/j.jid.2022.02.019. Epub 2022 Mar 22.
10
Beyond health-related quality of life: initial psychometric validation of a new scale for addressing the gap in assessing the full range of alopecia areata psychosocial burden.超越与健康相关的生活质量:评估斑秃患者全面心理负担的新量表的初步心理测量验证。
Br J Dermatol. 2023 Jul 7;189(1):71-79. doi: 10.1093/bjd/ljad054.

引用本文的文献

1
Components of Severity in Alopecia Areata.斑秃严重程度的组成部分。
Skin Appendage Disord. 2025 Apr 17:1-6. doi: 10.1159/000545861.

本文引用的文献

1
Global, regional and national epidemiology of alopecia areata: a systematic review and modelling study.斑秃的全球、区域和国家流行病学:系统评价和建模研究。
Br J Dermatol. 2024 Aug 14;191(3):325-335. doi: 10.1093/bjd/ljae058.
2
Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries.医生和患者报告的斑秃严重程度及对生活质量的影响:来自五个欧洲国家的真实世界调查结果
Dermatol Ther (Heidelb). 2023 Dec;13(12):3121-3135. doi: 10.1007/s13555-023-01057-0. Epub 2023 Oct 27.
3
Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways.
斑秃的心理应激发病机制:自身免疫和细胞凋亡途径。
Int J Mol Sci. 2023 Jul 20;24(14):11711. doi: 10.3390/ijms241411711.
4
Baricitinib as the first systemic treatment for severe alopecia areata.巴瑞替尼作为严重斑秃的首种系统性治疗药物。
Expert Rev Clin Immunol. 2023 Jun;19(6):565-573. doi: 10.1080/1744666X.2023.2200166. Epub 2023 Apr 12.
5
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).两项 III 期临床试验(BRAVE-AA1 和 BRAVE-AA2)中连续治疗 52 周时巴瑞替尼治疗严重斑秃患者的疗效和安全性。
Am J Clin Dermatol. 2023 May;24(3):443-451. doi: 10.1007/s40257-023-00764-w. Epub 2023 Mar 1.
6
Systematic Review of Psychological Interventions for Quality of Life, Mental Health, and Hair Growth in Alopecia Areata and Scarring Alopecia.斑秃和瘢痕性脱发患者生活质量、心理健康及头发生长的心理干预系统评价
J Clin Med. 2023 Jan 26;12(3):964. doi: 10.3390/jcm12030964.
7
A tutorial on Bayesian single-test reliability analysis with JASP.JASP 贝叶斯单测可靠性分析教程。
Behav Res Methods. 2023 Apr;55(3):1069-1078. doi: 10.3758/s13428-021-01778-0. Epub 2022 May 17.
8
The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata.斑秃患者报告的脱发严重程度与健康相关生活质量及治疗模式之间的关系
Dermatol Ther (Heidelb). 2022 Apr;12(4):989-997. doi: 10.1007/s13555-022-00702-4. Epub 2022 Mar 29.
9
Predictors of QOL in Patients with Alopecia Areata.斑秃患者生活质量的预测因素。
J Invest Dermatol. 2022 Oct;142(10):2646-2650.e3. doi: 10.1016/j.jid.2022.02.019. Epub 2022 Mar 22.
10
Body dysmorphia in common skin diseases: results of an observational, cross-sectional multicentre study among dermatological outpatients in 17 European countries.常见皮肤病中的躯体变形障碍:17 个欧洲国家皮肤科门诊患者中一项观察性、横断面多中心研究的结果。
Br J Dermatol. 2022 Jul;187(1):115-125. doi: 10.1111/bjd.21021. Epub 2022 May 22.